Procter & Gamble Hygiene and Health Care Limited PGHH NSE
Company Overview
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Why Investors Should Care
Generates a return on equity of 113.7%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 135.4%.
Net profit has compounded at 14.2% per year over the last five years.
Maintains a net profit margin of 20.0%.
Carries low leverage with a debt-to-equity ratio of 0.12.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹4,281.59 Cr (+2.1% YoY); net profit ₹856.50 Cr.
- Trailing 12 Months Year-on-year growth — revenue +2.1%, earnings +26.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.1%, profit CAGR 14.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 4.13% |
| 1 Year: | 2.15% |
Compounded Profit Growth
| 5 Years: | 14.16% |
| 1 Year: | 26.89% |
Stock Price Performance
| 1 Year: | -31.31% |
| 6 Months: | -28.34% |
| 3 Months: | -10.02% |
| 1 Month: | -1.30% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)40.50 · Neutral
P/E of 42.68 is above the sector median of 23.79 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 113.7%.
- Healthy ROCE of 135.4%.
- Profit CAGR of 14.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 37.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PGHH Procter & Gamble Hygiene and Health Care Limited NSE | 8,875.00 | 42.68 | ₹28,808.90 Cr | 1.34% | 135.44% | 113.67% | 4.13% | 14.16% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,115.10 | 33.05 | ₹4.97 L Cr | 2.05% | 22.15% | 30.86% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 276.25 | 16.73 | ₹3.46 L Cr | 5.68% | 36.47% | 28.53% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,431.80 | 86.10 | ₹2.76 L Cr | 0.82% | 62.44% | 79.99% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 3,911.80 | 85.73 | ₹2.55 L Cr | 0.00% | 16.41% | 12.14% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 469.60 | 52.29 | ₹1.59 L Cr | 0.42% | 19.44% | 15.51% | 17.26% | 26.57% |
| 7 | BRITANNIA Britannia Industries Limited NSE | 5,325.50 | 50.63 | ₹1.28 L Cr | 1.69% | 61.27% | 49.61% | 5.66% | 2.95% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 847.70 | 62.38 | ₹1.10 L Cr | 0.47% | 38.75% | 41.85% | 11.82% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,060.60 | 58.31 | ₹1.09 L Cr | 1.84% | 21.44% | 14.71% | 4.59% | 3.02% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 989.13 Cr | 935.16 Cr | 1,148.85 Cr | 1,259.91 Cr | 937.67 Cr |
| Cost of Revenue | - | 394.73 Cr | 341.17 Cr | 445.20 Cr | 421.97 Cr | 356.81 Cr |
| Gross Profit | - | 594.40 Cr | 593.99 Cr | 703.65 Cr | 837.94 Cr | 580.86 Cr |
| Operating Expenses | - | 395.10 Cr | 336.91 Cr | 428.17 Cr | 445.64 Cr | 372.11 Cr |
| Operating Income | - | 199.30 Cr | 257.08 Cr | 275.48 Cr | 392.30 Cr | 208.75 Cr |
| EBITDA | - | 228.78 Cr | 273.86 Cr | 294.66 Cr | 414.21 Cr | 230.78 Cr |
| Interest Expense | - | 5.77 Cr | 7.00 L | 3.60 Cr | 2.67 Cr | 3.11 Cr |
| Pretax Income | - | 212.66 Cr | 264.70 Cr | 281.78 Cr | 402.04 Cr | 218.11 Cr |
| Tax Provision | - | 56.56 Cr | 72.64 Cr | 71.92 Cr | 100.58 Cr | 64.98 Cr |
| Net Income | - | 156.10 Cr | 192.06 Cr | 209.86 Cr | 301.46 Cr | 153.13 Cr |
| Diluted EPS | - | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 3,792.45 Cr | 3,905.21 Cr | 4,191.57 Cr | 4,281.59 Cr |
| Cost of Revenue | - | 1,762.11 Cr | 1,880.82 Cr | 1,839.16 Cr | 1,565.15 Cr |
| Gross Profit | - | 2,030.34 Cr | 2,024.39 Cr | 2,352.41 Cr | 2,716.44 Cr |
| Operating Expenses | - | 1,235.90 Cr | 1,199.96 Cr | 1,403.55 Cr | 1,582.83 Cr |
| Operating Income | - | 794.44 Cr | 824.43 Cr | 948.86 Cr | 1,133.61 Cr |
| EBITDA | - | 854.21 Cr | 909.21 Cr | 1,022.70 Cr | 1,213.51 Cr |
| Interest Expense | - | 11.19 Cr | 11.38 Cr | 27.00 Cr | 9.45 Cr |
| Pretax Income | - | 790.14 Cr | 839.47 Cr | 939.20 Cr | 1,166.63 Cr |
| Tax Provision | - | 214.39 Cr | 161.33 Cr | 264.18 Cr | 310.13 Cr |
| Net Income | - | 575.75 Cr | 678.14 Cr | 675.02 Cr | 856.50 Cr |
| Diluted EPS | 200.79 | 177.37 | 208.91 | 207.95 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 1,682.57 Cr | 2,137.32 Cr | 1,858.56 Cr | 1,803.54 Cr |
| Current Assets | - | 1,135.09 Cr | 1,495.70 Cr | 1,199.68 Cr | 1,143.97 Cr |
| Cash & Equivalents | - | 624.98 Cr | 963.83 Cr | 573.67 Cr | 557.02 Cr |
| Inventory | - | 234.02 Cr | 219.80 Cr | 225.56 Cr | 217.93 Cr |
| Receivables | - | 192.08 Cr | 216.28 Cr | 240.83 Cr | 242.77 Cr |
| Total Liabilities | - | 945.00 Cr | 1,191.29 Cr | 1,083.70 Cr | 1,050.07 Cr |
| Current Liabilities | - | 859.63 Cr | 1,085.03 Cr | 980.66 Cr | 935.23 Cr |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 5.10 Cr | 4.03 Cr | 3.08 Cr | 87.00 L |
| Total Equity | - | 737.57 Cr | 946.03 Cr | 774.86 Cr | 753.47 Cr |
| Shares Outstanding | - | 3.25 Cr | 3.25 Cr | 3.25 Cr | 3.25 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 573.10 Cr | 825.77 Cr | 470.53 Cr | 924.08 Cr |
| Investing Cash Flow | - | -26.85 Cr | -9.91 Cr | 1.06 Cr | 11.37 Cr |
| Financing Cash Flow | - | -568.94 Cr | -477.01 Cr | -861.75 Cr | -844.80 Cr |
| Capital Expenditure | - | -49.80 Cr | -44.44 Cr | -44.68 Cr | -49.54 Cr |
| Free Cash Flow | - | 523.30 Cr | 781.33 Cr | 425.85 Cr | 874.54 Cr |
| Net Change in Cash | - | -22.69 Cr | 338.85 Cr | -390.16 Cr | 90.65 Cr |
Ratios (Annual)
Figures in %.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 53.5% | 51.8% | 56.1% | 63.4% |
| Operating Margin % | - | 20.9% | 21.1% | 22.6% | 26.5% |
| Net Margin % | - | 15.2% | 17.4% | 16.1% | 20.0% |
| ROE % | - | 78.1% | 71.7% | 87.1% | 113.7% |
| ROCE % | - | 96.5% | 78.3% | 108.1% | 130.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PGHH
PGHH Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE91YjRjdFVZV21uNGpYczdtX1d2cjdRRkhiMlFQbE1DTkYxYnBYTzVTNlZ5blhEc0N5dFVrYmdCRWtpX0t3RDlZNndid3RXbWtuQmlVYzl5MjZKNTlFOURlLU02WktRYmFsdlM3Y2VSV0FqNHVlSUE?oc=5" target="_blank">PGHH For…
Investors in Procter & Gamble Hygiene and Health Care (NSE:PGHH) have unfortunately lost 18% over the last year - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxPd3FoWXRmd2hqUEtrNC1tSWtUU2JtMGNXYzZhZTFnQW00RWlub1ltU2lFRkJEa3hyb29DQ1hzLW9pVFRqZ1YwYnFHY2Z3Sm9JX0ZEY3U2cVpQRW1tUWZ3ZnROQ3p5TWtQNFdjenpuSk94ajlFdTctNmN4c19XcXVBTTBSMF95SzM2MjZjUm…
Procter & Gamble Hygiene & Health Care Ltd. Trade Ideas — BSE:PGHH - TradingView
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5hbHVSOWx4d2NidGM0MnFpNnZvUnNVWjF6YV9nbHJid0FGcDlKcTJMNXd4VU85RXBuYmRMQTRCYWQtajVKaDJDcnRRT1otRlppU3E4VU80RFR1RHc5VXJ0Tw?oc=5" target="_blank">Procter & Gamble Hygiene & Health Car…
Unpleasant Surprises Could Be In Store For Procter & Gamble Hygiene and Health Care Limited's (NSE:PGHH) Shares - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxOTWl5ZFNyOE1MbFBYR0RVSmNnQkZzREpyb1FfMWRVRVkxOHhGT01fb3dxWmFzS0pMOTFkMnNzUjk3OUxiaFRrc016LU5JaHNFVjhVMUlKQ3ZTdk53Nk1hR0R0Ylhqb3RaSTBtdS1TQXdJbndRTnhJTk5tWThMNkM0SGxfTDFValBMRTJkeE…
PGHH Appoints Mohit Pradhan as VP to Lead 65% Revenue Contributing Feminine Hygiene Segment - Sahi
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNLVZxN1BCQ1hobnVIOTBFVmZCR2QtckM2T09fUV8xQ0lkRE1yV241LUVKYzFzY2hYTmJVTlZlWUhBbktiY0d4MjFJWWtQQXRTZzA2clE5ZWZjUzBRV1pDS1N4anlONVVvMElGSkRsRHZpNThOeTEzM1RwVGhTekxvVXlzdVJxazROUmR2NU…
P&G Hygiene promoter transfers 1.91% stake for ₹557.43 crore - scanx.trade
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQVXRjVUJuT1hkMHRDVi1QTXdVaFkySW16ZmtHSkI4Sl8yb3dsVU1vbDhDckNRMDZNY04xc3o1Vm5jMWxSRHFxYThfMENnVWczaWNVblhGdTVHM2tocGJDaWdxT0FPVGF5NWduQkM4UDRPakNvRGJ5RTdOMkczTlZCbEd6bzRxeXFhY2I1Nz…
PGHH — Frequently Asked Questions
What is the current share price of Procter & Gamble Hygiene and Health Care Limited (PGHH)?
As of 2026-07-15 09:52 IST, Procter & Gamble Hygiene and Health Care Limited (PGHH) trades at ₹8,875.00 on NSE. Its 52-week range is ₹8,813.00 to ₹14,146.50.
What is the market capitalisation of PGHH?
Procter & Gamble Hygiene and Health Care Limited (PGHH) has a market capitalisation of ₹28,808.90 Cr on NSE.
What is the P/E ratio of PGHH?
PGHH trades at a trailing price-to-earnings (P/E) ratio of 42.68. The industry average P/E is 23.79. Its price-to-book (P/B) ratio is 38.37.
Does PGHH pay a dividend?
Procter & Gamble Hygiene and Health Care Limited (PGHH) currently offers a dividend yield of 1.34%.
What is the return on equity (ROE) of PGHH?
PGHH has a return on equity (ROE) of 113.67%. Its return on capital employed (ROCE) is 135.44%.
Is PGHH a good stock to buy?
This page provides a data-driven analysis of Procter & Gamble Hygiene and Health Care Limited (PGHH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.